+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fluralaner Market by Animal Species (Animals With Special Needs, Cats, Dogs), Indication Type (Flea Control, Mite Control, Tick Control), Distribution Channel, Product Formulation, End User Profile, Product Lifecycle Stage - Global Forecast to 2030- Product Image
Fluralaner Market by Animal Species (Animals With Special Needs, Cats, Dogs), Indication Type (Flea Control, Mite Control, Tick Control), Distribution Channel, Product Formulation, End User Profile, Product Lifecycle Stage - Global Forecast to 2030- Product Image
Sale

Fluralaner Market by Animal Species (Animals With Special Needs, Cats, Dogs), Indication Type (Flea Control, Mite Control, Tick Control), Distribution Channel, Product Formulation, End User Profile, Product Lifecycle Stage - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6159255
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Fluralaner has emerged as a pioneering antiparasitic agent, redefining parasite management in veterinary medicine through its extended-duration efficacy and favorable safety profile. Since its introduction, this isoxazoline class compound has demonstrated robust activity against fleas, mites and ticks, addressing longstanding challenges such as tick resistance and frequent dosing burdens. As resistance to traditional parasiticides intensifies, fluralaner’s prolonged protection window has accelerated its adoption across diverse veterinary practices, fostering improved animal welfare and client satisfaction.

This executive summary synthesizes the pivotal trends and market forces shaping fluralaner’s strategic trajectory. It examines the transformative shifts driven by regulatory evolutions, technological advancements and shifting stakeholder expectations. Furthermore, it evaluates how United States tariff adjustments effective in 2025 reverberate through supply chains and pricing structures. Building on this foundation, the analysis delivers deep segmentation intelligence, regional nuances and competitive positioning of leading stakeholders.

By integrating actionable insights with a forward-looking perspective, this document equips decision-makers with the clarity needed to navigate complex dynamics. Whether exploring investment opportunities, optimizing distribution strategies or enhancing product portfolios, stakeholders will find a comprehensive framework to inform sustainable growth initiatives. The ensuing sections reveal the cumulative impact of policy changes, dissect market sub-segments and highlight proven strategies to fortify market leadership in an evolving landscape.

Transformative Shifts Defining the Fluralaner Landscape

The fluralaner ecosystem has undergone several transformative shifts, driven by converging scientific breakthroughs, regulatory recalibrations and evolving customer expectations. Advances in formulation science have enabled novel oral chewable tablets and long-acting injectables, which improve adherence and minimize treatment gaps. Concurrently, robust safety data generated through post-market surveillance has fortified confidence among veterinary professionals and pet owners alike.

Regulatory bodies globally have streamlined approval pathways for isoxazoline derivatives, accelerating market entry and enhancing product lifecycle efficiency. Emerging digital platforms and telemedicine channels have further disrupted traditional distribution models, enabling direct engagement with end users and real-time treatment monitoring. At the same time, growing environmental and sustainability mandates have prompted manufacturers to optimize supply chains and reduce ecological footprints, influencing sourcing strategies for active pharmaceutical ingredients.

Finally, the rise of data-driven resistance tracking, particularly in tick populations, has spurred tailored treatment regimens that preserve fluralaner’s efficacy and prolong its utility. Together, these shifts underscore a landscape in which adaptive innovation and strategic agility are paramount for capturing long-term value and maintaining competitive differentiation.

Cumulative Impact of United States Tariffs in 2025 on Fluralaner

The implementation of revised United States tariffs in 2025 has had a multi-layered impact on the fluralaner value chain. Increased duties on key chemical precursors have heightened raw material costs, prompting manufacturers to renegotiate contracts and explore alternative sourcing corridors. Production facilities heavily reliant on affected imports have accelerated efforts to localize manufacturing, thereby insulating operations from further trade policy volatility.

On the distribution front, elevated tariff burdens have translated into upward pricing pressure for end users, particularly within channels such as retail pharmacies and wholesale distribution networks. In response, several industry leaders have restructured supply agreements and leveraged economies of scale to absorb cost increases, while some have opted for tiered pricing models aligned with geographic purchasing power. Strategic alliances with domestic contract development and manufacturing organizations have emerged as a vital lever for cost containment, enabling sustained market access despite policy headwinds.

Key Segmentation Insights Shaping Market Dynamics

Analyzing animal species segmentation reveals that canine populations continue to represent the largest revenue stream, with small breed dogs showing heightened preference for easy-to-administer oral formulations. Large breed dogs benefit significantly from extended-duration injectables in clinical settings specializing in orthopedic and systemic care, while cats and exotic species such as ferrets and birds are driving niche growth through specialized dosing schedules. Additionally, the animals with special needs category, encompassing geriatric and immunocompromised patients, places a premium on fluralaner’s favorable safety margin.

Within indication type, tick control remains the fastest-growing segment, fueled by emerging tick resistance profiles that demand potent, long-acting solutions. Flea control continues to contribute substantial volume, while mite control exhibits steady adoption, particularly where dermatological sensitivity necessitates precise dosing. The emerging tick resistance sub-segment underscores the need for integrated surveillance protocols and combination therapies.

Distribution channels are rapidly evolving as online platforms gain market share, driven by direct-to-consumer models and subscription-based fulfillment services. Retail pharmacies maintain stable growth, benefiting from over-the-counter accessibility, while veterinary clinics uphold their role as primary prescribers. Wholesale distribution remains critical for large-scale institutional purchases, particularly in shelter and breeding operations.

Examining product formulation, chelatable tablets dominate oral usage, supported by palatability enhancements, whereas liquid formulations address dosing flexibility for exotic and pediatric applications. Topical applications sustain relevance among owners seeking non-systemic options, and injectables serve specialized clinical protocols. End user profiles reveal that pet owners are increasingly self-educating through digital resources, while veterinary professionals-both general practitioners and specialized clinicians-drive adoption through evidence-based recommendations.

Across the product lifecycle, commercialization efforts focus on market expansion and brand differentiation, whereas ongoing research and development programs target next-generation isoxazolines. Regulatory approval sequences vary by region but increasingly prioritize harmonized data packages, and post-market surveillance activities provide critical insights into long-term safety and resistance trends.

Regional Insights Illuminating Geographical Trends

In the Americas, robust demand for advanced antiparasitic treatments is underpinned by comprehensive veterinary care infrastructure and a sizeable companion animal population. Regulatory harmonization across the United States, Canada and Latin America facilitates cross-border product introductions, while consumer willingness to invest in premium formats drives innovation in chewable and injectable offerings.

The Europe, Middle East & Africa region presents a mosaic of regulatory frameworks and market maturity levels. Western Europe’s established channels and stringent safety standards foster rapid uptake of new fluralaner variants, whereas emerging markets in Eastern Europe and the Middle East prioritize cost-effective access, prompting tiered pricing strategies. In Africa, growth prospects hinge on improving veterinary networks and addressing endemic tick-borne diseases through targeted public-private partnerships.

Asia-Pacific is poised for the fastest expansion, fueled by rising pet ownership in urban centers across China, India and Southeast Asia. Regulatory bodies in Australia and Japan have adopted accelerated approval routes for isoxazoline analogs, while digital veterinary services proliferate in highly digitized economies. Supply chain resilience remains a focal point, with near-shoring initiatives mitigating potential disruptions associated with global trade dynamics.

Key Company Insights Driving Innovation and Market Leadership

Global heavyweights such as Bayer Animal Health, Merck Animal Health, Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Animal Health, Virbac and Vetoquinol continue to command significant market share through extensive R&D pipelines and established distribution networks. Their capacity to integrate fluralaner into diversified portfolios and leverage global marketing platforms sustains leadership in key regions.

Mid-tier innovators-including AlphaVet Pharmaceuticals, BetaVet Research, Epsilon Animal Science, FurMed Technologies, Gamma Animal Health, Omega Veterinary Innovations, Phibro Animal Health Corporation, Precision Veterinary Solutions, NexGen Pet Pharma and PetWell Pharma-are gaining traction by focusing on niche formulations and strategic partnerships. These players are adept at rapid response to emerging resistance patterns and often collaborate with contract manufacturing organizations to scale production efficiently.

Emerging specialists such as AnimalHealth Innovations, Apex Animal Care, Delta Pet Care, Dechra Pharmaceuticals, Global Animal Health Corp., Idexx Laboratories, Norbrook Laboratories, PrimoVets, Sunrise Animal Health, Synnovate Veterinary Solutions, Universal Vet Medicines and VetGuard Industries are differentiating through localized market expertise and agile go-to-market strategies. Their strength lies in customizing fluralaner delivery formats for regional end user preferences and forging alliances with veterinary networks to accelerate adoption.

Collectively, these competitive dynamics illustrate a landscape in which large incumbents leverage scale and depth of data, while agile challengers capitalize on specialization and speed to market. Strategic collaborations, co-development agreements and M&A activity are intensifying as companies vie for technological leadership and broader geographic reach.

Actionable Recommendations for Industry Leaders

First, industry leaders should enhance supply chain resilience by diversifying raw material sources and forging partnerships with domestic manufacturing sites to mitigate tariff-related cost pressures. Second, investment in palatable oral formats-particularly chewable tablets customized for small breed dogs-will capture increasing demand from conscientious pet owners. Third, integrating resistance monitoring protocols into post-market surveillance frameworks will preserve fluralaner’s efficacy and reinforce veterinarian confidence.

Next, leveraging digital platforms and telemedicine services can expand reach to pet owners in underserved regions, while subscription models ensure consistent treatment adherence. Additionally, deepening engagement with specialized clinicians through targeted education programs will drive endorsement of advanced formulations such as injectables for complex cases. Finally, pursuing expansion in high-growth markets-particularly within Asia-Pacific-requires a calibrated approach combining regulatory alignment, localized marketing initiatives and value-based pricing structures.

Conclusion on Fluralaner’s Strategic Trajectory

Fluralaner’s evolution underscores the imperative for strategic agility and innovation in veterinary therapeutics. The convergence of regulatory streamlining, advanced formulations and data-driven resistance management heralds a new era in parasite control. Organizations that proactively adapt supply chains, invest in next-generation delivery formats and strengthen partnerships with veterinary professionals will solidify competitive defenses.

Moreover, tailoring strategies to regional nuances-whether addressing tiered pricing demands in EMEA or capitalizing on digital veterinary services in Asia-Pacific-will unlock opportunities for sustained growth. By aligning product development roadmaps with emerging clinical needs and environmental sustainability goals, stakeholders can ensure that fluralaner continues to deliver superior outcomes for animals and end users alike.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Species
    • Animals With Special Needs
    • Cats
    • Dogs
      • Large Breed Dogs
      • Small Breed Dogs
    • Exotic Animals
  • Indication Type
    • Flea Control
    • Mite Control
    • Tick Control
      • Emerging Tick Resistance
  • Distribution Channel
    • Online Platforms
    • Retail Pharmacies
    • Veterinary Clinics
    • Wholesale Distribution
  • Product Formulation
    • Injectable Forms
    • Oral Forms
      • Chewable Tablets
      • Liquid Formulations
    • Topical Applications
  • End User Profile
    • Pet Owners
    • Veterinary Professionals
      • General Practitioners
      • Specialized Clinicians
  • Product Lifecycle Stage
    • Commercialization
    • Post Market Surveillance
    • Regulatory Approval
    • Research and Development
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • AlphaVet Pharmaceuticals
  • AnimalHealth Innovations
  • Apex Animal Care
  • Bayer Animal Health
  • BetaVet Research
  • Boehringer Ingelheim Animal Health
  • Ceva Animal Health
  • Dechra Pharmaceuticals
  • Delta Pet Care
  • Elanco Animal Health
  • Epsilon Animal Science
  • FurMed Technologies
  • Gamma Animal Health
  • Global Animal Health Corp.
  • Idexx Laboratories
  • Merck Animal Health
  • NexGen Pet Pharma
  • Norbrook Laboratories
  • Omega Veterinary Innovations
  • PetWell Pharma
  • Phibro Animal Health Corporation
  • Precision Veterinary Solutions
  • PrimoVets
  • Sunrise Animal Health
  • Synnovate Veterinary Solutions
  • Universal Vet Medicines
  • VetGuard Industries
  • Vetoquinol
  • Virbac
  • Zoetis Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Fluralaner Market, by Animal Species
8.1. Introduction
8.2. Animals With Special Needs
8.3. Cats
8.4. Dogs
8.4.1. Large Breed Dogs
8.4.2. Small Breed Dogs
8.5. Exotic Animals
9. Fluralaner Market, by Indication Type
9.1. Introduction
9.2. Flea Control
9.3. Mite Control
9.4. Tick Control
9.4.1. Emerging Tick Resistance
10. Fluralaner Market, by Distribution Channel
10.1. Introduction
10.2. Online Platforms
10.3. Retail Pharmacies
10.4. Veterinary Clinics
10.5. Wholesale Distribution
11. Fluralaner Market, by Product Formulation
11.1. Introduction
11.2. Injectable Forms
11.3. Oral Forms
11.3.1. Chewable Tablets
11.3.2. Liquid Formulations
11.4. Topical Applications
12. Fluralaner Market, by End User Profile
12.1. Introduction
12.2. Pet Owners
12.3. Veterinary Professionals
12.3.1. General Practitioners
12.3.2. Specialized Clinicians
13. Fluralaner Market, by Product Lifecycle Stage
13.1. Introduction
13.2. Commercialization
13.3. Post Market Surveillance
13.4. Regulatory Approval
13.5. Research And Development
14. Americas Fluralaner Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Fluralaner Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Fluralaner Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AlphaVet Pharmaceuticals
17.3.2. AnimalHealth Innovations
17.3.3. Apex Animal Care
17.3.4. Bayer Animal Health
17.3.5. BetaVet Research
17.3.6. Boehringer Ingelheim Animal Health
17.3.7. Ceva Animal Health
17.3.8. Dechra Pharmaceuticals
17.3.9. Delta Pet Care
17.3.10. Elanco Animal Health
17.3.11. Epsilon Animal Science
17.3.12. FurMed Technologies
17.3.13. Gamma Animal Health
17.3.14. Global Animal Health Corp.
17.3.15. Idexx Laboratories
17.3.16. Merck Animal Health
17.3.17. NexGen Pet Pharma
17.3.18. Norbrook Laboratories
17.3.19. Omega Veterinary Innovations
17.3.20. PetWell Pharma
17.3.21. Phibro Animal Health Corporation
17.3.22. Precision Veterinary Solutions
17.3.23. PrimoVets
17.3.24. Sunrise Animal Health
17.3.25. Synnovate Veterinary Solutions
17.3.26. Universal Vet Medicines
17.3.27. VetGuard Industries
17.3.28. Vetoquinol
17.3.29. Virbac
17.3.30. Zoetis Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. FLURALANER MARKET MULTI-CURRENCY
FIGURE 2. FLURALANER MARKET MULTI-LANGUAGE
FIGURE 3. FLURALANER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL FLURALANER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL FLURALANER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FLURALANER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FLURALANER MARKET SIZE, BY INDICATION TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FLURALANER MARKET SIZE, BY INDICATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL FLURALANER MARKET SIZE, BY END USER PROFILE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL FLURALANER MARKET SIZE, BY END USER PROFILE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS FLURALANER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS FLURALANER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES FLURALANER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES FLURALANER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC FLURALANER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC FLURALANER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. FLURALANER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. FLURALANER MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. FLURALANER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FLURALANER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FLURALANER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FLURALANER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL FLURALANER MARKET SIZE, BY ANIMALS WITH SPECIAL NEEDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FLURALANER MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FLURALANER MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FLURALANER MARKET SIZE, BY LARGE BREED DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FLURALANER MARKET SIZE, BY SMALL BREED DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FLURALANER MARKET SIZE, BY EXOTIC ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FLURALANER MARKET SIZE, BY FLEA CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FLURALANER MARKET SIZE, BY MITE CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FLURALANER MARKET SIZE, BY TICK CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FLURALANER MARKET SIZE, BY EMERGING TICK RESISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FLURALANER MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FLURALANER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FLURALANER MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FLURALANER MARKET SIZE, BY WHOLESALE DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FLURALANER MARKET SIZE, BY INJECTABLE FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FLURALANER MARKET SIZE, BY ORAL FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FLURALANER MARKET SIZE, BY CHEWABLE TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FLURALANER MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FLURALANER MARKET SIZE, BY TOPICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL FLURALANER MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL FLURALANER MARKET SIZE, BY GENERAL PRACTITIONERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL FLURALANER MARKET SIZE, BY SPECIALIZED CLINICIANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL FLURALANER MARKET SIZE, BY COMMERCIALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL FLURALANER MARKET SIZE, BY POST MARKET SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL FLURALANER MARKET SIZE, BY REGULATORY APPROVAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL FLURALANER MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS FLURALANER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 74. CANADA FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 75. CANADA FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 76. CANADA FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 77. CANADA FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 78. CANADA FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. CANADA FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 81. CANADA FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 82. CANADA FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 83. CANADA FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 85. MEXICO FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 88. MEXICO FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. MEXICO FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 90. MEXICO FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 93. MEXICO FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES FLURALANER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC FLURALANER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 126. CHINA FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 127. CHINA FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 128. CHINA FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 129. CHINA FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 130. CHINA FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. CHINA FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. CHINA FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 133. CHINA FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 134. CHINA FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 135. CHINA FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 136. INDIA FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 137. INDIA FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 138. INDIA FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 139. INDIA FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 140. INDIA FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. INDIA FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. INDIA FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 143. INDIA FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 144. INDIA FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 145. INDIA FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 156. JAPAN FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 157. JAPAN FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 158. JAPAN FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 159. JAPAN FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 160. JAPAN FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. JAPAN FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. JAPAN FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 163. JAPAN FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 164. JAPAN FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 165. JAPAN FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 215. TAIWAN FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 216. THAILAND FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 217. THAILAND FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 218. THAILAND FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 219. THAILAND FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 220. THAILAND FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. THAILAND FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 222. THAILAND FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 223. THAILAND FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 224. THAILAND FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 225. THAILAND FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA FLURALANER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 247. DENMARK FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 248. DENMARK FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 249. DENMARK FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 250. DENMARK FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 251. DENMARK FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. DENMARK FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 253. DENMARK FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 256. DENMARK FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 257. EGYPT FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 258. EGYPT FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 259. EGYPT FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 260. EGYPT FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 261. EGYPT FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. EGYPT FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 263. EGYPT FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 264. EGYPT FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 265. EGYPT FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 266. EGYPT FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 267. FINLAND FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 268. FINLAND FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 269. FINLAND FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 270. FINLAND FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 271. FINLAND FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. FINLAND FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 273. FINLAND FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 274. FINLAND FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 275. FINLAND FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 276. FINLAND FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 277. FRANCE FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 278. FRANCE FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 279. FRANCE FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 280. FRANCE FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 281. FRANCE FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. FRANCE FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 283. FRANCE FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 284. FRANCE FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 285. FRANCE FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 286. FRANCE FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 287. GERMANY FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 288. GERMANY FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 289. GERMANY FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 290. GERMANY FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 291. GERMANY FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. GERMANY FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 293. GERMANY FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 294. GERMANY FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 295. GERMANY FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 296. GERMANY FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 306. ISRAEL FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 307. ITALY FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 308. ITALY FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 309. ITALY FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 310. ITALY FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 311. ITALY FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. ITALY FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 313. ITALY FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 314. ITALY FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 315. ITALY FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 316. ITALY FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 327. NIGERIA FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 328. NIGERIA FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 329. NIGERIA FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 330. NIGERIA FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 337. NORWAY FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 338. NORWAY FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 339. NORWAY FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 340. NORWAY FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 341. NORWAY FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 342. NORWAY FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 343. NORWAY FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 344. NORWAY FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 345. NORWAY FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 346. NORWAY FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 347. POLAND FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 348. POLAND FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 349. POLAND FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 350. POLAND FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 351. POLAND FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 352. POLAND FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 353. POLAND FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 354. POLAND FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 355. POLAND FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 356. POLAND FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 357. QATAR FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 358. QATAR FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 359. QATAR FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 360. QATAR FLURALANER MARKET SIZE, BY TICK CONTROL, 2018-2030 (USD MILLION)
TABLE 361. QATAR FLURALANER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 362. QATAR FLURALANER MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 363. QATAR FLURALANER MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 364. QATAR FLURALANER MARKET SIZE, BY END USER PROFILE, 2018-2030 (USD MILLION)
TABLE 365. QATAR FLURALANER MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 366. QATAR FLURALANER MARKET SIZE, BY PRODUCT LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 367. RUSSIA FLURALANER MARKET SIZE, BY ANIMAL SPECIES, 2018-2030 (USD MILLION)
TABLE 368. RUSSIA FLURALANER MARKET SIZE, BY DOGS, 2018-2030 (USD MILLION)
TABLE 369. RUSSIA FLURALANER MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Fluralaner market report include:
  • AlphaVet Pharmaceuticals
  • AnimalHealth Innovations
  • Apex Animal Care
  • Bayer Animal Health
  • BetaVet Research
  • Boehringer Ingelheim Animal Health
  • Ceva Animal Health
  • Dechra Pharmaceuticals
  • Delta Pet Care
  • Elanco Animal Health
  • Epsilon Animal Science
  • FurMed Technologies
  • Gamma Animal Health
  • Global Animal Health Corp.
  • Idexx Laboratories
  • Merck Animal Health
  • NexGen Pet Pharma
  • Norbrook Laboratories
  • Omega Veterinary Innovations
  • PetWell Pharma
  • Phibro Animal Health Corporation
  • Precision Veterinary Solutions
  • PrimoVets
  • Sunrise Animal Health
  • Synnovate Veterinary Solutions
  • Universal Vet Medicines
  • VetGuard Industries
  • Vetoquinol
  • Virbac
  • Zoetis Inc.

Related Topics

Related Reports

Plumb's Veterinary Drug Handbook. Edition No. 10 - Product Image

Plumb's Veterinary Drug Handbook. Edition No. 10

  • Book
  • 1568 Pages
Veterinary Lyme Disease Vaccine Market by Animal Type (Dog, Horse), Vaccine Type (Bacterin Inactivated, Recombinant, Subunit), End User, Distribution Channel, Administration Route, Formulation - Global Forecast 2025-2030 - Product Image

Veterinary Lyme Disease Vaccine Market by Animal Type (Dog, Horse), Vaccine Type (Bacterin Inactivated, Recombinant, Subunit), End User, Distribution Channel, Administration Route, Formulation - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Oclacitinib Maleate Market by Clinical Applications, Formulation Types, Animal Species, Sales Channels, Pricing Models, Regulatory Approvals, Manufacturing Processes, Research and Development - Global Forecast to 2030 - Product Image

Oclacitinib Maleate Market by Clinical Applications, Formulation Types, Animal Species, Sales Channels, Pricing Models, Regulatory Approvals, Manufacturing Processes, Research and Development - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Pet Cancer Therapeutics Market by Distribution Channel (Online Pharmacies, Specialty Clinics, Veterinary Hospitals), Animal Type (Cats, Dogs), Drug Class, Therapy Type, Formulation, Line of Therapy, Cancer Type - Global Forecast 2025-2030 - Product Image

Pet Cancer Therapeutics Market by Distribution Channel (Online Pharmacies, Specialty Clinics, Veterinary Hospitals), Animal Type (Cats, Dogs), Drug Class, Therapy Type, Formulation, Line of Therapy, Cancer Type - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Animal Pharmaceuticals Market by Product Type (Anesthetics, Anti-Inflammatory Medications, Antibiotics), Species (Aquatic Animals, Birds, Companion Animals), Route of Administration, Disease Type, End User, Distribution Channels - Global Forecast 2025-2030 - Product Image

Animal Pharmaceuticals Market by Product Type (Anesthetics, Anti-Inflammatory Medications, Antibiotics), Species (Aquatic Animals, Birds, Companion Animals), Route of Administration, Disease Type, End User, Distribution Channels - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.